NASAL CAVITY CANCER

This adverse event was reported 917 times

These drugs are most commonly taken by patients reporting NASAL CAVITY CANCER:

# Drug Count
0 RANITIDINE 222
1 RANITIDINE HYDROCHLORIDE 170
2 METHOTREXATE SODIUM 26
3 ADALIMUMAB 23
4 METHOTREXATE 21
5 PREDNISONE 21
6 CYCLOPHOSPHAMIDE 19
7 CYCLOPHOSPHAMIDE FOR INJECTION 19
8 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 19
9 ETANERCEPT 19
See all common drugs associated with NASAL CAVITY CANCER

NASAL CAVITY CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RANITIDINE HYDROCHLORIDE 170 0.0031
1 TALIGLUCERASE ALFA 1 0.0017
2 RANITIDINE 222 0.0011
3 METYRAPONE 1 0.0010
4 PENTOSTATIN 1 0.0010
5 INFLIXIMAB-DYYB 3 0.0009
6 SODIUM CITRATE 1 0.0008
7 PIOGLITAZONE HYDROCHLORIDE 1 0.0008
8 GLYCEROL PHENYLBUTYRATE 1 0.0007
9 LEMBOREXANT 2 0.0007
See all drugs enriched for association with NASAL CAVITY CANCER